Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $42,993 | 26 | 40.3% |
| Honoraria | $29,293 | 13 | 27.4% |
| Travel and Lodging | $21,357 | 56 | 20.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,199 | 13 | 6.7% |
| Food and Beverage | $5,866 | 72 | 5.5% |
| Education | $69.57 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| H. Lundbeck A S | $35,830 | 29 | $0 (2023) |
| Alkermes, Inc. | $21,947 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,977 | 28 | $0 (2024) |
| Indivior Inc. | $11,979 | 17 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $9,768 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $5,106 | 5 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $3,480 | 2 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $2,133 | 13 | $0 (2022) |
| F. Hoffmann-La Roche AG | $1,758 | 5 | $0 (2019) |
| Janssen Research & Development, LLC | $1,264 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,722 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,593) |
| 2023 | $11,672 | 28 | H. Lundbeck A S ($5,358) |
| 2022 | $6,373 | 5 | H. Lundbeck A S ($4,510) |
| 2021 | $14,847 | 9 | H. Lundbeck A S ($13,107) |
| 2020 | $15,502 | 27 | H. Lundbeck A S ($8,140) |
| 2019 | $9,425 | 18 | H. Lundbeck A S ($4,715) |
| 2018 | $31,668 | 52 | Alkermes, Inc. ($10,826) |
| 2017 | $2,569 | 22 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,292) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,843.75 | General |
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,785.00 | General |
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $140.00 | General |
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 06/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,478.75 | General |
| 05/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $113.52 | General |
| Category: Neuropsychiatry | ||||||
| 05/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $124.65 | General |
| 05/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $45.47 | General |
| 04/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $122.43 | General |
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $41.63 | General |
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $34.48 | General |
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.17 | General |
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.66 | General |
| 04/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $279.00 | General |
| 04/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $605.17 | General |
| 02/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Consulting Fee | Cash or cash equivalent | $1,320.00 | General |
| Category: CNS | ||||||
| 01/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Travel and Lodging | In-kind items and services | $1,060.30 | General |
| Category: CNS | ||||||
| 01/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Travel and Lodging | In-kind items and services | $271.00 | General |
| Category: CNS | ||||||
| 01/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $215.48 | General |
| Category: CNS | ||||||
| 01/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $121.09 | General |
| Category: CNS | ||||||
| 07/03/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: CNS | ||||||
| 05/11/2023 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Honoraria | Cash or cash equivalent | $4,038.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/11/2023 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Travel and Lodging | Cash or cash equivalent | $535.90 | General |
| Category: PSYCHIATRY | ||||||
| 05/11/2023 | H. Lundbeck A S | ABILIFY MAINTENA (Drug) | Travel and Lodging | Cash or cash equivalent | $335.44 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 30 | $3,569 | $481.55 |
| 2022 | 6 | 145 | 445 | $83,592 | $18,571 |
| 2021 | 6 | 184 | 681 | $128,759 | $31,188 |
| 2020 | 1 | 57 | 334 | $116,900 | $27,682 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,356 | $414.60 | 17.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 17 | $1,212 | $66.95 | 5.5% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 35 | 132 | $47,652 | $10,755 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 54 | $11,122 | $2,851 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 28 | $6,752 | $2,472 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 38 | 198 | $14,121 | $1,324 | 9.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 14 | $1,190 | $608.69 | 51.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 19 | $2,755 | $559.64 | 20.3% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 56 | 265 | $94,312 | $22,128 | 23.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 30 | 47 | $3,995 | $2,829 | 70.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 40 | 290 | $20,469 | $2,790 | 13.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 30 | $6,179 | $1,850 | 29.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 25 | 34 | $1,700 | $1,071 | 63.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 15 | $2,104 | $519.48 | 24.7% |
| 90870 | Shock treatment and monitoring | Facility | 2020 | 57 | 334 | $116,900 | $27,682 | 23.7% |
About Dr. Eric Achtyes, MD
Dr. Eric Achtyes, MD is a Psychiatry healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780665976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Achtyes, MD has received a total of $106,778 in payments from pharmaceutical and medical device companies, with $14,722 received in 2024. These payments were reported across 182 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($42,993).
As a Medicare-enrolled provider, Achtyes has provided services to 413 Medicare beneficiaries, totaling 1,490 services with total Medicare billing of $77,922. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Grand Rapids, MI
- Active Since 11/07/2005
- Last Updated 01/25/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780665976
Products in Payments
- ABILIFY MAINTENA (Drug) $32,820
- PERSERIS (Drug) $9,906
- Aristada 441 mg (Drug) $8,170
- ARISTADA (Drug) $7,613
- INGREZZA (Drug) $4,718
- BRINTELLIX (Drug) $3,010
- AUSTEDO (Drug) $1,845
- INVEGA TRINZA (Drug) $1,277
- SYMTUZA (Drug) $111.71
- COBENFY (Drug) $27.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Grand Rapids
Vajendra Desai, Md, MD
Psychiatry — Payments: $41,356
Robert Lafleur, D.o, D.O
Psychiatry — Payments: $20,244
Puneet Singla, Md, MD
Psychiatry — Payments: $13,478
Dr. Bobga Fomunung, Md, MD
Psychiatry — Payments: $9,053
Dr. Joseph Niezer, Md, MD
Psychiatry — Payments: $4,212
Michael Michelakis, Md, MD
Psychiatry — Payments: $2,977